Global Blood Therapeutics' IPO

Global Blood Therapeutics raised a round of funding on August 12, 2015. Investors include Public.

Global Blood Therapeutics (GBT) is a biopharmaceutical company developing novel small molecule therapeutics for the treatment of severe blood disorders. The company is addressing serious, non-malignan…

Articles about Global Blood Therapeutics' IPO: